A comparison of chemo-free strategy with G-CSF plus plerixafor on demand versus intermediate-dose cyclophosphamide and G-CSF as PBSC mobilization in newly diagnosed multiple myeloma patients: An Italian explorative cost Analysis

Autor: Laszlo, D. *, Marcacci, GP., Martino, M., Radice, D., Rabascio, C., Lucchetti, B., Magarò, A., Caime, A., Menna, S., Lionetti, MT., Bertolini, F.
Zdroj: In Transfusion and Apheresis Science October 2020 59(5)
Databáze: ScienceDirect